ArticleFrontiers in medicine2026

Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world study.

Yuting Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.